Committed to sharing our science

Committed to sharing our science

scientist testing potential medicines

315 results available

Aficamten is Associated with Improvements in Cardiac Mechanics in Obstructive Hypertrophic Cardiomyopathy: Results from the FOREST-HCM Trial

Poser, American Society of Echocardiography 2023
Chen M, et al.
National Harbor, MD
June 25, 2023
Plasma Neurofilament Analysis in VITALITY-ALS

Poster, ENCALS 2023
Simkins TJ, et al
Barcelona, Spain
July 12, 2023
Time from ALS Symptom Onset to Key Disease Milestones for Slow, Intermediate, and Fast Progressors: a Real-World Cross-Sectional Survey

Poster, ENCALS 2023
Gebrehiwet P, et al
Barcelona, Spain
July 12, 2023
Evaluation of Aficamten in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy: REDWOOD HCM Cohort 4

Presentation, European Society of Cardiology Heart Failure 2023
Masri A, et al
Prague, Czech Republic
May 20, 2023
Long-Term Efficacy and Safety of Aficamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Poster, ACC.23
Saberi S, et al
New Orleans, LA
March 4, 2023